Bradley Miller M.D.

Bradley Miller MD, PhD is an experienced leader in the pharmaceutical and academic sectors, currently serving as Vice President of Translational and Precision Medicine, Pharmacology, Pharmacometrics and Oncology at Teva Pharmaceuticals since August 2020. Prior to this role, Bradley held key positions at Eli Lilly and Company, including Senior Managing Director of the Neuroscience Division, where strategic oversight of initiatives from discovery to late-phase clinical trials was managed. Additional experience includes serving as Executive Associate Director at the Garrison Institute on Aging and Assistant Professor in Pathology and Neurology at Texas Tech University Health Sciences Center. Bradley's educational background includes an MD and PhD from Virginia Commonwealth University School of Medicine, a BS in Biology from William & Mary, and specialized training in Pathology at the University of Virginia.